GKB Ophthalmics Ltd
Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic
- Market Cap ₹ 32.8 Cr.
- Current Price ₹ 65.0
- High / Low ₹ 112 / 59.0
- Stock P/E
- Book Value ₹ 103
- Dividend Yield 0.00 %
- ROCE -6.00 %
- ROE -12.7 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.63 times its book value
- Debtor days have improved from 112 to 85.4 days.
- Company's working capital requirements have reduced from 103 days to 77.6 days
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -5.60% over last 3 years.
- Contingent liabilities of Rs.17.9 Cr.
- Promoter holding has decreased over last 3 years: -8.10%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | 35 | 44 | 76 | 78 | 57 | 59 | 57 | 71 | 75 | 88 | 109 | 115 | |
| 34 | 34 | 44 | 75 | 77 | 56 | 56 | 55 | 66 | 72 | 88 | 112 | 118 | |
| Operating Profit | 8 | 1 | -1 | 2 | 1 | 1 | 2 | 2 | 5 | 4 | 1 | -3 | -3 |
| OPM % | 18% | 2% | -2% | 2% | 2% | 2% | 4% | 4% | 7% | 5% | 1% | -3% | -3% |
| 1 | 1 | 12 | 4 | 0 | 2 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | |
| Interest | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 3 |
| Depreciation | 1 | 2 | 1 | 1 | 2 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 5 | -2 | 8 | 3 | -1 | -2 | -2 | -1 | 2 | 0 | -3 | -7 | -7 |
| Tax % | 46% | -37% | 50% | 12% | -15% | -30% | -0% | -19% | -0% | 14% | 8% | 5% | |
| 4 | -0 | 4 | 3 | -1 | -1 | -2 | -1 | 2 | 0 | -3 | -7 | -8 | |
| EPS in Rs | 9.61 | -0.00 | 9.51 | 6.24 | -2.34 | -2.37 | -3.65 | -1.81 | 2.52 | -0.34 | -5.57 | -13.97 | -15.51 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 15% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -118% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 4% |
| 3 Years: | -19% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -3% |
| 3 Years: | -6% |
| Last Year: | -13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 36 | 36 | 41 | 43 | 41 | 50 | 54 | 58 | 58 | 58 | 55 | 47 |
| 13 | 9 | 7 | 7 | 10 | 14 | 15 | 12 | 12 | 11 | 11 | 14 | |
| 21 | 26 | 17 | 28 | 28 | 25 | 28 | 32 | 35 | 38 | 43 | 59 | |
| Total Liabilities | 73 | 75 | 69 | 82 | 83 | 94 | 102 | 107 | 110 | 112 | 114 | 125 |
| 14 | 12 | 13 | 18 | 18 | 26 | 26 | 24 | 23 | 19 | 18 | 17 | |
| CWIP | 1 | 1 | 1 | 1 | 0 | -0 | -0 | 1 | 3 | 4 | 4 | 4 |
| Investments | 15 | 16 | 10 | 3 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| 44 | 46 | 46 | 60 | 64 | 68 | 75 | 80 | 82 | 87 | 91 | 102 | |
| Total Assets | 73 | 75 | 69 | 82 | 83 | 94 | 102 | 107 | 110 | 112 | 114 | 125 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 7 | -11 | -3 | -3 | 4 | 3 | 7 | 5 | -3 | 4 | -3 | |
| -2 | -0 | 15 | 4 | 1 | -10 | -4 | -17 | -4 | 1 | -2 | 3 | |
| -5 | -6 | -3 | -1 | 1 | 13 | 4 | 3 | -2 | -2 | -2 | 1 | |
| Net Cash Flow | -0 | 1 | 0 | -1 | 0 | 7 | 4 | -7 | -0 | -4 | 1 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 185 | 191 | 143 | 118 | 129 | 150 | 155 | 125 | 100 | 134 | 117 | 85 |
| Inventory Days | 345 | 424 | 285 | 225 | 223 | 289 | 301 | 349 | 307 | 298 | 245 | 250 |
| Days Payable | 163 | 343 | 156 | 169 | 168 | 217 | 234 | 234 | 208 | 183 | 202 | 195 |
| Cash Conversion Cycle | 367 | 271 | 272 | 174 | 184 | 222 | 223 | 239 | 199 | 249 | 160 | 141 |
| Working Capital Days | 101 | 97 | 156 | 111 | 115 | 110 | 110 | 117 | 105 | 135 | 97 | 78 |
| ROCE % | 14% | -0% | -1% | 3% | 0% | -2% | -1% | 3% | 4% | 2% | -1% | -6% |
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 3 Nov
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 3 Nov
-
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30,2025
28 Oct - Board meeting on Nov 14, 2025 to approve unaudited results for quarter/half ended Sep 30, 2025.
-
Intimation Of Reduction In Production And Manpower At The Company''s Plant Situated At Tivim Industrial Estate,Goa.
11 Oct - Plant production cut to 50% from Oct 2025; US export orders stopped; temporary worker releases.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Oct - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30,2025. Kindly acknowledge receipt of the same.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39